Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
Authors
Keywords
Melanoma, Acute allograft rejection, Organ transplant, Hemodialysis, Anti-PD-1 therapy, Nivolumab
Journal
Journal for ImmunoTherapy of Cancer
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-07
DOI
10.1186/s40425-016-0171-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy
- (2016) C. L. Boils et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection
- (2016) T. Alhamad et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma
- (2016) L. Spain et al. ANNALS OF ONCOLOGY
- Belatacept and Long-Term Outcomes in Kidney Transplantation
- (2016) Flavio Vincenti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Regression and Allograft Rejection after Administration of Anti–PD-1
- (2016) Evan J. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD1-Expressing T Cell Subsets Modify the Rejection Risk in Renal Transplant Patients
- (2016) Rebecca Pike et al. Frontiers in Immunology
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Administration of Ipilimumab to a Liver Transplant Recipient With Unresectable Metastatic Melanoma
- (2015) Harsha A. Ranganath et al. JOURNAL OF IMMUNOTHERAPY
- Post-transplantation malignancies: here today, gone tomorrow?
- (2015) Edward K. Geissler Nature Reviews Clinical Oncology
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation
- (2015) Rita E Morales et al. Journal for ImmunoTherapy of Cancer
- Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma
- (2014) Evan J. Lipson et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of the PD-1 Pathway in the Immune Response
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Essential Role of PDL1 Expression on Nonhematopoietic Donor Cells in Acquired Tolerance to Vascularized Cardiac Allografts
- (2011) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Malignant Melanoma in Solid Transplant Recipients
- (2011) Jerry D. Brewer ARCHIVES OF DERMATOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Cancer incidence and risk factors after solid organ transplantation
- (2009) Claire M. Vajdic et al. INTERNATIONAL JOURNAL OF CANCER
- PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation
- (2008) Maria-Luisa del Rio et al. TRANSPLANT INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started